{"transactions":[{"id":672735,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18637,"kind":"person","name":"Garzone Pamela","position":1,"cik":"0001974756","reported_name":"Garzone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T17:04:26.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to correct an administrative calculation error in Column 4 of Table I of the original filing relating to a grant of restricted stock units (\"RSUs\") to the Reporting Person, which resulted in the number of securities acquired by the Reporting Person being overstated. The original filing incorrectly reported 21,800 shares; the correct amount of shares acquired is 18,900. As a result of this correction, the total amount of securities beneficially owned following the reported transaction in Column 5 has been updated to 18,900. One-third of the shares subject to the RSU vest on each of July 9, 2027, July 9, 2028 and July 9, 2029, subject to the Reporting Person's continued service with the Issuer through each such vest date."}],"balance_after":18900,"source":{"system":"sec-edgar","filing":"0001974756-26-000006","document":"form4a-08282026_090821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000197475626000006/form4a-08282026_090821.xml","form_type":"4/A","original_submission_date":"2026-07-10"}},{"id":711019,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18637,"kind":"person","name":"Garzone Pamela","position":1,"cik":"0001974756","reported_name":"Garzone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T23:37:59.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"). One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date."}],"balance_after":21800,"source":{"system":"sec-edgar","filing":"0001974756-26-000004","document":"form4-07102026_110755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000197475626000004/form4-07102026_110755.xml","form_type":"4"}},{"id":945650,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18637,"kind":"person","name":"Garzone Pamela","position":1,"cik":"0001974756","reported_name":"Garzone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:00:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option becomes fully exercisable on the first anniversary of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":0.34,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0001193125-26-004356","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526004356/ownership.xml","form_type":"4"}},{"id":1313345,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18637,"kind":"person","name":"Garzone Pamela","position":1,"cik":"0001974756","reported_name":"Garzone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T21:00:17.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":1.09,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0000950170-25-001101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025001101/ownership.xml","form_type":"4"}},{"id":1686912,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18637,"kind":"person","name":"Garzone Pamela","position":1,"cik":"0001974756","reported_name":"Garzone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:02:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":2.78,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0000950170-24-001833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024001833/ownership.xml","form_type":"4"}},{"id":1915453,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18637,"kind":"person","name":"Garzone Pamela","position":1,"cik":"0001974756","reported_name":"Garzone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-21T20:15:23.000Z","date":"2023-04-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments."}],"balance_after":40000,"derivative":{"exercise_price":3.46,"expiration_date":"2033-04-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-025142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123025142/doc4.xml","form_type":"4"}}]}